| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/21/2008 | WO2008020901A2 Separation of proteins from grasses integrated with ammonia fiber explosion (afex) pretreatment and cellulose hydrolysis |
| 02/21/2008 | WO2008020656A1 A dna vaccine for curing chronic hepatitis b and a method of preparing same |
| 02/21/2008 | WO2008020435A2 Compositions and methods for treatment of mood disorders |
| 02/21/2008 | WO2008019486A1 Nucleic acid modulation of toll-like receptor-mediated immune stimulation |
| 02/21/2008 | WO2007140410A9 Low-density lipoprotein receptor 6 (lrp6) as a mammary stem cell marker and related methods |
| 02/21/2008 | WO2007126887A3 Immunogenic compositions comprising polynucleotides encoding matrix protein 2 and methods of use |
| 02/21/2008 | WO2007124148A3 Treatment of connective tissue disorders |
| 02/21/2008 | WO2006089340A3 Polynucleotide delivery to cardiac tissue |
| 02/21/2008 | WO2006073458A3 Oligonucleotides comprising a c5-modified pyrimidine |
| 02/21/2008 | US20080047035 Plasmid which utilizes recombination for efficient genic transfer into host genomes; genetic engineering |
| 02/21/2008 | US20080045474 Method for treatment of invasive cells |
| 02/21/2008 | US20080045471 Nucleic Acids For Apoptosis Of Cancer Cells |
| 02/21/2008 | US20080044465 Therapy for cellular accumulation in chronic inflammatory diseases |
| 02/21/2008 | US20080044426 Novel Atypical Pneumonia-Causing Virus |
| 02/21/2008 | US20080044395 In Vitro Method for Isolating, Proliferating and Differentiating Germ-Line Stem Cells |
| 02/21/2008 | US20080044394 Methods for genetic modification of hematopietic progenitor cells and uses of the modified cells |
| 02/21/2008 | US20080044391 Different dendritic cell subsets |
| 02/21/2008 | US20080044389 Mortierella schmuckeri microorganisms are cultured in fermentation medium; a polyunsaturated fatty acid for use in food products, nutraceuticals e.g. infant formulas |
| 02/21/2008 | US20080044388 Method for Production of Arachidonic Acid |
| 02/21/2008 | US20080044387 Artificial niches for enhancement of regenerative capacity of stem cells in aged and pathological environments |
| 02/21/2008 | US20080044386 Protamine-Adenoviral Vector Complexes and Methods of Use |
| 02/21/2008 | US20080044385 Novel Modified Galectin 8 Proteins and Use Thereof |
| 02/21/2008 | US20080044377 Poxvirus Vector Encoding Retrovirus (Eg Hiv) And Cytokine |
| 02/21/2008 | US20080042818 Trailer tire alert system |
| 02/21/2008 | CA2660204A1 Nucleic acid modulation of toll-like receptor-mediated immune stimulation |
| 02/20/2008 | EP1889914A1 Compositions for gene therapy of diabetes |
| 02/20/2008 | EP1889913A1 Transcription factor islet-brain 1 (IB1) |
| 02/20/2008 | EP1889912A1 Transcriptions Factor Islet-Brain 1 (IB1) |
| 02/20/2008 | EP1889911A2 An antisense oligonucleotide preparation method |
| 02/20/2008 | EP1889905A1 Method for amelioration of disease condition induced by mood disorder |
| 02/20/2008 | EP1889633A1 Medicinal compositions for angiogenic therapy |
| 02/20/2008 | EP1889631A1 Cell growth inhibition |
| 02/20/2008 | EP1889626A1 Hip kinase for fertility control |
| 02/20/2008 | EP1889058A1 Diagnosis and treatment of endometriosis |
| 02/20/2008 | EP1888758A2 Transduction of primary cells |
| 02/20/2008 | EP1888622A1 Compositions for inducing an immune response against hepatitis b |
| 02/20/2008 | EP1406667B1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/20/2008 | EP1163349B1 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 02/20/2008 | EP1112497B1 Ykl-40 as a marker and prognostic indicator for cancers and detection of infections |
| 02/20/2008 | EP1007672B1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways |
| 02/20/2008 | EP0907746B1 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 02/20/2008 | CN101128593A Method for reversing multiple resistance in animal cells |
| 02/20/2008 | CN101126098A Small disturbance RNA molecule expression carrier for differentially inhibiting GFAP protein expression and its construction method and use thereof |
| 02/20/2008 | CN101126095A Genetic immunization with nonstructural proteins of hepatitis c virus |
| 02/20/2008 | CN101126094A Genetic immunization with nonstructural proteins of hepatitis c virus |
| 02/20/2008 | CN100370025C Small interference RNA inhibiting the expression of 1A6/DRIM gene and its action site |
| 02/19/2008 | USRE40089 Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor |
| 02/19/2008 | US7332590 Using serial analysis of gene expression to identify tumor marker gene transcription products in respiratory system tissues; diagnosing/prognosing lung cancer |
| 02/19/2008 | US7332586 Active agent and a nuclear localization signal and methods of modulating gene expression and protein expression employing the nanoparticle delivery vehicle. A representative method includes providing a nanoparticle delivery vehicle comprising |
| 02/19/2008 | US7332579 Antiproliferative agents; anticancer agents |
| 02/19/2008 | US7332572 Using type II membrane glycoprotein (4F2hc) as tool in identifying modulator which inhibit transcription in tumor cells; gene expresion inhibition and antitumors agents |
| 02/19/2008 | US7332478 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 02/19/2008 | US7332477 Visible light and ultraviolet (UV) light sensitive composition for DNA transfer comprising an acid sensitive gene transfer agent, a photoacid generator, and a bioactive agent |
| 02/19/2008 | US7332354 bioconjugation; luciferins; biopolymer labels |
| 02/19/2008 | US7332337 Viral vectors having tissue tropism for T-lymphocytes, B- and mast cells |
| 02/19/2008 | US7332335 Increasing expression of p21WAF1/Cip 1 in cells to decrease proliferation of the cells by decreasing levels of PP5 protein in the cells. |
| 02/19/2008 | US7332332 Mixture comprising sodium and potassium ions for use in transfer of exogenous nucleotide sequences into cells; genetic engineering and heterologous gene expression |
| 02/19/2008 | US7332293 Neutral amino acid transporter binding method |
| 02/19/2008 | US7332287 Methods and compositions for diagnosing breast cancer |
| 02/19/2008 | US7332276 Administering steroid compound |
| 02/19/2008 | US7332169 Avian-paramyxovirus nucleotide sequence; attenuation live vaccine |
| 02/19/2008 | US7332156 Methods of treating wounds using IL-23 |
| 02/19/2008 | CA2289702C High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
| 02/19/2008 | CA2267668C Method for enhancing the efficiency of gene transfer with stem cell factor polypeptide |
| 02/19/2008 | CA2209858C Il-2r-associated polypeptide and dna molecules coding therefor |
| 02/19/2008 | CA2205175C A polynucleotide tuberculosis vaccine |
| 02/14/2008 | WO2008019351A2 Compositions and their uses directed to diacylglycerol acyltransferase 1 |
| 02/14/2008 | WO2008018555A1 HBsAg PARTICLE HAVING LOW ANTIGENICITY AND METHOD FOR PRODUCTION THEREOF |
| 02/14/2008 | WO2008018517A1 Therapeutic and/or preventive agent for disease accompanied by cell overgrowth, and polynucleotide useful as the active ingredient |
| 02/14/2008 | WO2008017859A2 Ligand for the g6b receptor on blood platelets |
| 02/14/2008 | WO2008017636A2 Genes and proteins of brachyspira hyodysenteriae and uses thereof |
| 02/14/2008 | WO2008017568A1 Plasmids with immunological action |
| 02/14/2008 | WO2008017126A1 Treatment of pulmonary disease conditions |
| 02/14/2008 | WO2007146309A9 Methods for manipulating stem cells |
| 02/14/2008 | WO2007132096A3 System for transposing hyperactive recombinant derivatives of mos-1 transposon |
| 02/14/2008 | WO2007120368A8 Immunostimulatory combinations for vaccine adjuvants |
| 02/14/2008 | US20080039419 Integrin-linked kinase and its uses |
| 02/14/2008 | US20080039415 Retrograde transport of sirna and therapeutic uses to treat neurologic disorders |
| 02/14/2008 | US20080039410 Inositol 1,4,5-Trisphosphate Receptor Mutants and Uses Thereof |
| 02/14/2008 | US20080039401 For allergy such as asthma; modulating interleukin (IL)-9 expression |
| 02/14/2008 | US20080039397 Polynucleotide encoding a tropoelastin polypeptide; expression products and hybrid molecules of the derivatives and variants |
| 02/14/2008 | US20080039390 Use of the insulin-like-growth factor I splice variant MGF for the prevention of myocardial damage |
| 02/14/2008 | US20080039364 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 02/14/2008 | US20080038824 Composition and Method for Elevating Gene Transfer Efficiency |
| 02/14/2008 | US20080038822 Virus clearance of neoplastic cells from mixed cellular compositions |
| 02/14/2008 | US20080038820 Induction of pluripotent stem cells into mesodermal lineages |
| 02/14/2008 | US20080038819 Micro Rna Inhibiting the Expression of Wt1 Gene and Utilization of the Same |
| 02/14/2008 | US20080038731 Diagnostics and therapeutic uses of topors |
| 02/14/2008 | US20080038330 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds of the lower respiratory tract |
| 02/14/2008 | US20080038312 Insertable or implantable medical devices suitable for gene therapy regimens |
| 02/14/2008 | US20080038297 Genetic adjuvants for viral vaccines |
| 02/14/2008 | US20080038269 Methods for detecting and treating kidney disease |
| 02/14/2008 | US20080038249 Treatment Of Neurodegenerative Diseases By The Use Of Laptm4a |
| 02/14/2008 | US20080038244 Materials and Methods Relating to Cell Cycle Control |
| 02/14/2008 | US20080038238 Human Stem Cell Materials and Methods |
| 02/14/2008 | US20080038237 Trojan horse immunotherapy |
| 02/14/2008 | US20080038234 Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair |
| 02/14/2008 | US20080038227 Animal model of neurodegenerative diseases, the procedure for producing the model and applications thereof |
| 02/14/2008 | US20080038205 Novel dermatophagoides proteins |
| 02/14/2008 | US20080038189 RNA interference mediated inhibition of aurorakinase B and its combinations as anticancer therapy |